These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30277144)
1. Flavonoids as P-gp Inhibitors: A Systematic Review of SARs. Cui J; Liu X; Chow LMC Curr Med Chem; 2019; 26(25):4799-4831. PubMed ID: 30277144 [TBL] [Abstract][Full Text] [Related]
2. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. Bansal T; Jaggi M; Khar RK; Talegaonkar S J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292 [TBL] [Abstract][Full Text] [Related]
3. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. Guz NR; Stermitz FR; Johnson JB; Beeson TD; Willen S; Hsiang J; Lewis K J Med Chem; 2001 Jan; 44(2):261-8. PubMed ID: 11170636 [TBL] [Abstract][Full Text] [Related]
4. Quantitative Structure⁻Activity Relationships for the Flavonoid-Mediated Inhibition of P-Glycoprotein in KB/MDR1 Cells. Xia M; Fang Y; Cao W; Liang F; Pan S; Xu X Molecules; 2019 Apr; 24(9):. PubMed ID: 31035631 [TBL] [Abstract][Full Text] [Related]
5. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR). Teodori E; Dei S; Martelli C; Scapecchi S Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship and mechanism of flavonoids on the inhibitory activity of P-glycoprotein (P-gp)-mediated transport of rhodamine123 and daunorubicin in P-gp overexpressed human mouth epidermal carcinoma (KB/MDR) cells. Fang Y; Liang F; Xia M; Cao W; Pan S; Wu T; Xu X Food Chem Toxicol; 2021 Sep; 155():112381. PubMed ID: 34217736 [TBL] [Abstract][Full Text] [Related]
7. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Di Pietro A; Conseil G; Pérez-Victoria JM; Dayan G; Baubichon-Cortay H; Trompier D; Steinfels E; Jault JM; de Wet H; Maitrejean M; Comte G; Boumendjel A; Mariotte AM; Dumontet C; McIntosh DB; Goffeau A; Castanys S; Gamarro F; Barron D Cell Mol Life Sci; 2002 Feb; 59(2):307-22. PubMed ID: 11915946 [TBL] [Abstract][Full Text] [Related]
8. Screening dietary flavonoids for the reversal of P-glycoprotein-mediated multidrug resistance in cancer. Mohana S; Ganesan M; Agilan B; Karthikeyan R; Srithar G; Beaulah Mary R; Ananthakrishnan D; Velmurugan D; Rajendra Prasad N; Ambudkar SV Mol Biosyst; 2016 Jul; 12(8):2458-70. PubMed ID: 27216424 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a Flavonoid FM04 as a Potent Inhibitor to Reverse P-Glycoprotein-Mediated Drug Resistance in Xenografts and Improve Oral Bioavailability of Paclitaxel. Kan JWY; Yan CSW; Wong ILK; Su X; Liu Z; Chan TH; Chow LMC Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499627 [TBL] [Abstract][Full Text] [Related]
10. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological strategies for overcoming multidrug resistance. Nobili S; Landini I; Giglioni B; Mini E Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217 [TBL] [Abstract][Full Text] [Related]
13. A New Class of Safe, Potent, and Specific P-gp Modulator: Flavonoid Dimer FD18 Reverses P-gp-Mediated Multidrug Resistance in Human Breast Xenograft in Vivo. Yan CS; Wong IL; Chan KF; Kan JW; Chong TC; Law MC; Zhao Y; Chan SW; Chan TH; Chow LM Mol Pharm; 2015 Oct; 12(10):3507-17. PubMed ID: 26291333 [TBL] [Abstract][Full Text] [Related]
14. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Critchfield JW; Welsh CJ; Phang JM; Yeh GC Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Boumendjel A; Di Pietro A; Dumontet C; Barron D Med Res Rev; 2002 Sep; 22(5):512-29. PubMed ID: 12210557 [TBL] [Abstract][Full Text] [Related]
16. Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Palmeira A; Sousa E; Vasconcelos MH; Pinto MM Curr Med Chem; 2012; 19(13):1946-2025. PubMed ID: 22257057 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the development of P-gp inhibitors. Baumert C; Hilgeroth A Anticancer Agents Med Chem; 2009 May; 9(4):415-36. PubMed ID: 19442042 [TBL] [Abstract][Full Text] [Related]
19. Can flavonoids from honey alter multidrug resistance? Jaganathan SK Med Hypotheses; 2011 Apr; 76(4):535-7. PubMed ID: 21247706 [TBL] [Abstract][Full Text] [Related]
20. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]